Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide

被引:52
作者
Viriyakosol, S
Mathison, JC
Tobias, PS
Kirkland, TN
机构
[1] Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Pathol,Infect Dis Sect, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA
[3] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.275.5.3144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD14 is a glycophosphatidylinositol-linked protein expressed by myeloid cells and also circulates as a plasma protein lacking the glycophosphatidylinositol anchor. Both membrane and soluble CD14 function to enhance activation of cells by lipopolysaccharide (LPS), which we refer to as receptor function. We have previously reported the LPS binding and cell activation functions of a group of five deletion mutants of CD14 (Viriyakosol, S., and Kirkland, T.N. (1995) J. Biol. Chem. 270, 361-368). We have now studied the functional impact of these mutations on soluble CD14. We found that some deletions that abrogated LPS binding in membrane CD14 have no effect on LPS binding in soluble CD14. In fact, some of the soluble CD14 deletion mutants bound LPS with an apparent higher affinity than wild-type CD14. Furthermore, we found that all five deletions essentially ablated soluble CD14 LPS receptor function, whereas only two of the deletions completely destroyed membrane CD14 LPS receptor function. Some of the mutants were able to compete with wild-type CD14 in soluble CD14-dependent assays of cellular activation. We concluded that the soluble and membrane forms of CD14 have different structural determinants for LPS receptor function.
引用
收藏
页码:3144 / 3149
页数:6
相关论文
共 36 条
[21]   CD14 RECEPTOR-MEDIATED UPTAKE OF NONOPSONIZED MYCOBACTERIUM-TUBERCULOSIS BY HUMAN MICROGLIA [J].
PETERSON, PK ;
GEKKER, G ;
HU, SX ;
SHENG, WS ;
ANDERSON, WR ;
ULEVITCH, RJ ;
TOBIAS, PS ;
GUSTAFSON, KV ;
MOLITOR, TW ;
CHAO, CC .
INFECTION AND IMMUNITY, 1995, 63 (04) :1598-1602
[22]   A CRITICAL ROLE FOR MONOCYTES AND CD14 IN ENDOTOXIN-INDUCED ENDOTHELIAL-CELL ACTIVATION [J].
PUGIN, J ;
ULEVITCH, RJ ;
TOBIAS, PS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2193-2200
[23]   LIPOPOLYSACCHARIDE ACTIVATION OF HUMAN ENDOTHELIAL AND EPITHELIAL-CELLS IS MEDIATED BY LIPOPOLYSACCHARIDE-BINDING PROTEIN AND SOLUBLE CD14 [J].
PUGIN, J ;
SCHURERMALY, CC ;
LETURCQ, D ;
MORIARTY, A ;
ULEVITCH, RJ ;
TOBIAS, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2744-2748
[24]   GRAM-NEGATIVE ENDOTOXIN - AN EXTRAORDINARY LIPID WITH PROFOUND EFFECTS ON EUKARYOTIC SIGNAL TRANSDUCTION [J].
RAETZ, CRH ;
ULEVITCH, RJ ;
WRIGHT, SD ;
SIBLEY, CH ;
DING, AH ;
NATHAN, CF .
FASEB JOURNAL, 1991, 5 (12) :2652-2660
[25]  
Sellati TJ, 1998, J IMMUNOL, V160, P5455
[26]   Identification of CD14 residues involved in specific lipopolysaccharide recognition [J].
Shapiro, RA ;
Cunningham, MD ;
Ratcliffe, K ;
Seachord, C ;
Blake, J ;
Bajorath, J ;
Aruffo, A ;
Darveau, RP .
INFECTION AND IMMUNITY, 1997, 65 (01) :293-297
[27]  
SIRIYAKOSOL S, 1995, CLIN INFECT DIS S2, V21, P190
[28]   Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS [J].
Tobias, PS ;
Soldau, K ;
Iovine, NM ;
Elsbach, P ;
Weiss, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18682-18685
[29]   LIPOPOLYSACCHARIDE-BINDING PROTEIN-MEDIATED COMPLEXATION OF LIPOPOLYSACCHARIDE WITH SOLUBLE CD14 [J].
TOBIAS, PS ;
SOLDAU, K ;
GEGNER, JA ;
MINTZ, D ;
ULEVITCH, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10482-10488
[30]   NEW FUNCTION FOR HIGH-DENSITY LIPOPROTEINS - ISOLATION AND CHARACTERIZATION OF A BACTERIAL LIPOPOLYSACCHARIDE HIGH-DENSITY LIPOPROTEIN COMPLEX FORMED IN RABBIT PLASMA [J].
ULEVITCH, RJ ;
JOHNSTON, AR ;
WEINSTEIN, DB .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (03) :827-837